28 October 2024
28 October 2024
A new vaccines drug substance facility and R&D pilot plant, completed by the end of 2028, will create over 200 new jobs.
US-based Lyell is expected to pay up to $30m in cash, along with shares and milestone-based payments.
The FDA's decision was based on results from two pivotal Phase III clinical trials, SURE 1 and REASSURE.
At the Outsourcing in Clinical Trials Conference, key opinion leaders shared predictions for workflow changes due to AI.
The Phase III ECZTEND study reported that patients treated with Adbry demonstrated long-term safety and efficacy for up to six years.
At the Outsourcing in Clinical Trials conference, Rohan Simon from the UAE CRO IROS spoke about the region’s clinical trials landscape.
Motivated patients with rare diseases are using social media widely, making it an effective way to reach patients for trial recruitment.
New research casts doubt on current advice recommending AF patients wait up to 14 days to receive anticoagulants after a stroke.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
